Search For "cdsco"
No recommendations for COVID-19 booster dose by SEC: Sources
Updated : 4 years, 3 months ago IST
New Delhi [India], December 11 (ANI): The Subject Expert Committee (SEC) under Central Drugs Standard Control Organization (CDSCO) has said COVID-19 that booster doses cannot be recommended without clinical trials.
Read More
Subject Expert Committee to meet tomorrow to discuss approval for Covishie
Updated : 4 years, 3 months ago IST
New Delhi [India], December 9 (ANI): The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) will hold the first meeting on Friday regarding the COVID-19 booster dose, said sources on Thursday.
Read More
COVID-19 vaccination for children: CDSCO approved ZyCoV-D for restricted u
Updated : 4 years, 3 months ago IST
New Delhi [India], November 30 (ANI): The Interim Phase II, III clinical trial data of COVAXIN on Healthy Volunteers aged 2 to 18 years submitted by Bharat Biotech was deliberated in the meeting of the Subject Expert Committee (SEC) on August 28 and October 11, informed Ministry of Health an
Read More
Medtronic Launches Arctic Front Advanced Cardiac Cryoablation Catheter Tec
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], November 9 (ANI/BusinessWire India): India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc -- a global leader in healthcare technology, today announced the launch of Arctic Front™ Cardiac Cryoablation Catheter System, the first and on
Read More
Approval for world's first DNA-based 'ZyCov-D' vaccine is testimony to inn
Updated : 4 years, 7 months ago IST
New Delhi [India], August 20 (ANI): Prime Minister Narendra Modi on Friday said that the approval for the world's first DNA-based 'ZyCov-D' vaccine of Zydus Cadila group is a testimony to the innovative zeal of India's scientists.
Read More
COVID-19: J&J applies for approval to conduct clinical trials on adole
Updated : 4 years, 7 months ago IST
New Delhi [India], August 20 (ANI): US pharma giant Johnson & Johnson has moved an application before the Central Drugs Standard Control Organisation (CDSCO) in India, seeking permission to conduct clinical trials of its single-dose Janssen vaccine against COVID-19 on adolescents (chi
Read More
Expert panel recommends trials on mixing Covaxin and Covishield
Updated : 4 years, 7 months ago IST
New Delhi [India], July 30 (ANI): The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) on Thursday recommended granting permission for trials of mixing COVID-19 vaccines--Covaxin and Covishield--said sources.
Read More
Zydus Cadila, first Indian Company gets recommendation for clinical trials
Updated : 4 years, 9 months ago IST
New Delhi [India], June 4 (ANI): The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 has been recommended to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drug
Read More
Lilly signs pact with Natco to accelerate availability of baricitinib for
Updated : 4 years, 10 months ago IST
New Delhi [India], May 17 (ANI): Eli Lilly and Company said on Monday it has issued an additional royalty-free, non-exclusive voluntary license to Natco Pharma, a local pharmaceutical manufacturer of generic medicines.
Read More
Lilly signs pacts with Cipla, Lupin, Sun Pharma to accelerate availability
Updated : 4 years, 10 months ago IST
New Delhi [India], May 10 (ANI): US pharmaceutical major Eli Lilly said on Monday it has issued royalty-free, non-exclusive voluntary licenses to Cipla, Lupin and Sun Pharmaceutical to accelerate and expand the availability of baricitinib in India for Covid-19 patients.
Read More
COVID-19: India to decide emergency use authorisation of Sputnik V vaccine
Updated : 4 years, 12 months ago IST
New Delhi [India], March 31 (ANI): Meeting of Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) will be held on Wednesday to deliberate on emergency use authorisation application of Russian vaccine Sputnik V.
Read More
SEC recommends Dr Reddy's to submit additional data for EUA of Sputnik V C
Updated : 5 years, 1 month ago IST
New Delhi [India], February 24 (ANI): The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) has recommended additional immunogenicity data from Dr Reddy's Laboratories which applied to the national drugs regulator seeking emergency use approval for Sputnik
Read More